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SYSTEMATIC REVIEW, Paul Ossman 
Background: Pulmonary rehabilitation is associated with an improved health 
related quality (HRQL) oflife and decreased hospital utilization over one year 
following rehabilitation, but not with decreased mortality or improved lung 
function. The sustainability of these improvements is controversial and the role 
of a pulmonary maintenance program or repeated pulmonary rehabilitation 
program is under investigation. 
Purpose: To examine the evidence regarding the effect of additional pulmonary 
rehabilitation or maintenance therapy, following the completion of a conventional 
pulmonary rehabilitation program. 
Data Sources: MEDLINE, the Cochrane Library, hand searching based on 
reviews and previous systematic reviews of pulmonary rehabilitation. 
Methods: Randomized controlled trials of exercise maintenance programs 
following an initial pulmonary rehabilitation program of at least 6 weeks duration 
with at least a 1 year of follow-up; studies that used defined and validated 
measurement tools; studies that accounted for the reliability and validity of 
measurement tools as well as patient characteristics; and randomized controlled 
trials with health outcomes. 
Population: Patients living with mild, moderate, or severe COPD 
Intervention: Additional pulmonary rehabilitation following an initial course of 
pulmonary rehabilitation of at least 6 weeks. 
Control: Short-term/acute pulmonary rehabilitation as defmed by a period of time 
less than or equal to 6 weeks of pulmonary rehabilitation program. 
Outcomes: HRQL, Mortality, Change in functional status (a six minute walk test, 
FEVl, etc.) 
Study Selection: Of 496 citations identified, 79 articles were reviewed to yield 3 
good to fair studies comparing exercise maintenance to usual care following an 
initial pulmonary rehabilitation program. 
Conclusion: Current research is sparse, yet it suggests that continued exercise 
maintenance therapy is associated with modest improvements in exercise 
capacity, but not with any difference in lung function. Results were not conclusive 
as to a benefit in HRQL or dyspnea. Additionally, the selection and recruitment 
bias that exists within the studies regarding pulmonary rehabilitation weakens the 
generalizability of the data reported. Further research is needed to confirm the 
associations and further investigate the affects ofHRQL and dyspnea following 
pulmonary rehabilitation and maintenance therapy. 
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INTRODUCTION 
Burden of Disease 
Chronic obstructive pulmonary disease (COPD) is a progressive chronic 
disease marked by chronic inflammation of the airways and lung parenchyma. 
This inflammation causes a limitation of airflow that is not fully reversible over 
time or with treatment.1 Patients with advanced COPD experience dyspnea, 
exercise intolerance, generalized muscle weakness and dystrophy, cardiac 
impairments (eg, cor pulmonale), and nutritional deficiencies."2 
According to estimates from the National Heart, Lung, and Blood 
Institute, the annual cost ofCOPD to the United States was $23.9 billion in 
19933.4 and has risen to $32.1 billion in 2002.4 Approximately 70% of this cost 
continues to be for inpatient hospitalization and emergency department care. 3-5 In 
2000, COPD related emergency department visits reached 1.5 million and 
119,000 adults died from COPD exacerbations.4•5 COPD is the 4th leading cause 
of death and is projected to be the 3'd leading cause of death in 2020.4•5 
Progression of Disease 
Due to the prolonged and variable asymptomatic phase of the disease and 
the varying levels of disease upon presentation, survival data are not conclusive; 
however, the long-term survival of patients living with symptomatic COPD, 
especially those who have been referred for puhnonary rehabilitation is poor. In a 
randomized trial of outpatient pulmonary rehabilitation, Ries, et. a!. found the 6-
year survival of the 119 patients with COPD was 61% and Gerardi et. a!. found 
the 3-year survival following outpatient puhnonary rehabilitation was 80%.6• 7 
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As COPD progresses, the forced expiratory volume in one second (FEVl) 
declines at an increasing rate. FEVl is the primary physiological abnormality in 
COPD, yet the onset of the symptomatic phase does not occur until the FEVl 
reaches approximately 50 percent of the predicted normal value. Additionally, 
the rate at which individual patients progress varies, as does how a patient will 
respond to therapy.1 Disease severity and strength are also related to outcomes 
following pulmonary rehabilitation. Troosters et. al. demonstrated that weaker 
patients with less severe disease were more likely to respond to exercise therapy.8 
However, compared to patients experiencing a severe impairment in HRQL, 
patients with a moderate impairment in HRQL will have a more significant 
deterioration of benefits despite a more significant improvement following 
rehabilitation.9 Personality traits may also affect the long term outcomes 
following pulmonary rehabilitation as they appear related to quality oflife and 
coping mechanisms.10 
Current Treatment 
The goals of current therapy are palliative and preventive in nature: 
symptom relief, improvement in physiological function, and limitation of 
exacerbations of the disease. Smoking cessation is a major goal of treatment as 
no other therapy reduces the rate oflung function decline as dramatically. 
Patients who quit smoking reduce their rate of lung-function decline by as much 
as 50%.11 Providers often offer pneumococcal vaccination and annual influenza 
vaccination as a precautionary measure despite the lack of direct evidence that 
these vaccines improve outcomes.12 Long and short acting inhaled 
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bronchodilators are the primary pharmaceutical intervention. They lessen 
symptoms, reduce exacerbations of disease, and improve the quality of life 
An initial pulmonary rehabilitation program is recognized as an effective 
therapy in terms of short term-outcomes. Several studies confirm short -term 
benefits of an initial pulmonary rehabilitation program: increased exercise 
capacity, easing of dyspnea, and improvement in the health quality oflife.1• 2· 13• 14• 
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benefits of pulmonary rehabilitation for COPD are discussed further in this paper 
in the discussion segment. 
The long term benefits of a pulmonary rehabilitation program are 
questionable as the improvements gained following a pulmonary rehabilitation 
program tend to diminish over time; even in the studies that show some sustained 
improvement following a pulmonary rehabilitation program, the improvements 
still trend towards the null as time from pulmonary rehabilitation increases. 6· 9· 22· 
34
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38 In this paper, I will investigate the role exercise maintenance plays in 
extending the benefits of an initial pulmonary rehabilitation program over time. 
As COPD advances, using supplemental oxygen to maintain an oxygen 
saturation of at least 90 per-cent at all times has been shown to prolong survival.2· 
39 Lastly, lung volume reduction surgery plays a controversial role in patients 
with severe disease. Lung volume reduction surgery does not lead to a reduction 
in mortality; however, the National Emphysema Treatment Trial found that a 
5 
subgroup of patients had an overall improvement in health status. Conversely, 
mortality was increased in a subgroup of patients with severe physiological 
impairment (FEVl,:::; 20 percent of the predicted normal value).40 
Thus far, domiciliary oxygen therapy and smoking cessation have been the 
only therapies found to prolong survival and slow the decline of lung functioning 
respectively,2 however, mortality and disease progression are only two of many 
outcomes that can measure a patient's health. 
Current Role of Pulmonary Rehabilitation 
Pnlmonary rehabilitation is similar to other exercise-based rehabilitation in 
that the participants benefit from therapy in three phases.41• 42 Participants 
experience initial benefits during the formal program. Then, the initial gains 
made in the program are transferred into gains in physical performance. Lastly, 
these gains are maintained over time. Most studies investigate the outcomes 
during the initial stage. There is growing data on the first year following 
rehabilitation, but very few studies investigate the role of maintenance programs. 
There is currently a debate over the sustainability of benefits received 
from pnlmonary rehabilitation. Few studies investigate hospital usage after 12 
months and fewer studies investigate the cost-effectiveness of rehab. Studies 
have shown a clinically and statically significant improvement at the end of 
rehabilitation, but the studies that follow patients for at least one year find a 
deterioration of functioning reverting back towards baseline over the year 
following the completion of pulmonary rehabilitation. 6• 31• 36• 37• 43• 44 The quality 
of these studies is problematic due to the number of drop outs and eligible patients 
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who chose not to participate.36• 37• 43• 44 A more thorough discussion of these 
articles and the problems with patient compliance appears later in this paper. 
Three randomized controlled trials studies with validated outcome 
measures indicate that benefits derived from pulmonary rehabilitation can persist 
over time (greater than 1 year after completion of therapy) without maintenance, 
but patients do begin to deteriorate by the end of follow-up. 22, 34• 45 These three 
studies also have problems with compliance and patient drop-out, but Griffiths et. 
al. use an intention to treat (ITT) analysis in an effort to account for poor 
compliance. Length and intensity of the program may contribute to the difference 
found in these three studies. Troosters et. al. and Guell et. al. studied patients who 
completed a course of rehabilitation that was longer than most programs ( 6 
months rather than 6 to 8 weeks). Griffiths et. al. studied patients who 
participated in an intensive multidisciplinary program rather than exercise alone. 
The fmdings of Lacasse et. al. support the association between better 
outcomes and a rehabilitation program lasting 6 months and longer. In a 
Cochrane Collaboration systematic review, Lacasse et. al. identified 7 quality 
studies of rehabilitation programs with a duration <6 months and 3 quality studies 
of rehabilitation programs with a duration c6 months. After meta-analysis, both 
groups of studies were associated with a clear benefit to patients, and the longer 
programs were associated with a greater cumulative benefit. 18 Lacasse et. al. 
declined to review the long term benefits of pulmonary rehabilitation as "too few 
investigators have examined the long-term benefits of rehabilitation."18 
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As research continues on the lasting benefits of pulmonary rehabilitation 
and means to prolong the benefits following therapy, pulmonary rehabilitation 
continues to be recommended to patients. The American Thoracic Society 
recommends comprehensive pulmonary rehabilitation over standard medical 
management or educational management alone and recognize pulmonary 
rehabilitation provides benefits across several outcome areas: exercise ability, 
dyspnea, and improvement in health status.13 The American Association of Chest 
Physicians (AACP) support pulmonary rehabilitation "for any patient with stable 
disease of the respiratory system and disabling symptoms."21 The ACCP 
recognizes lower extremity training as the best studied modality to improve 
exercise tolerance stating that this modality is supported by several well-designed, 
well-conducted, controlled trials. Upper extremity training and ventilatory 
muscle training are also recommended, but lack the rich evidence base oflower 
extremity training.15' 21 
Methods 
Search Strategy and Study Selection 
I searched MEDLINE, The Cochrane Library, and hand searched relevant 
citations from previous systematic reviews of pulmonary rehabilitation for 
relevant studies to the key question: for patients living with COPD, what are the 
effects of a program of exercise maintenance following an initial pulmonary 
rehabilitation program? I used Medical Subject Headings (MeSH) search terms 
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as well as key words where appropriate.' I limited the search to "English 
language," and "human." Excluding hand-searches my literature search found 
496 citations, of which I reviewed 79 articles (See Table 1). 
I first retrieved the 496 abstracts of any article whose title suggested the 
article may contain data on pulmonary rehabilitation and COPD. The great 
majority of these abstracts were available through MEDLINE and those not 
available on MEDLINE were reviewed from the original article. I excluded only 
articles that clearly did not focus upon either pulmonary rehabilitation or COPD. 
I again excluded articles that clearly did not focus on an exercise maintenance 
program following pulmonary rehabilitation. 
Table 1: Search Strategy 
Key Question Search Strategy 
Articles Identified for abstract review/ Articles Identified for 
in depth review 
What are the COPD (MeSH and text word)+Rehabilitation 329150 
effects of (text word and subheading) + 
additional Quality of Life(MeSH and text word) 
pulmonary COPD (MeSH and text word)+Rehabilitation 13219 
rehabilitation (text word and subheading) +Long-term (all 
following an fields) (excluding repeats from above search) 
initial 6 week COP D (MeSH and text word)+ Rehabilitation 26111 
course of (text word and subheading) + 
pulmonary Maintenance(MeSH and text word) 
rehabilitation COPD (MeSH and text word)+ Rehabilitation 8/1 
(text word and subheading) + Postrehabilitation 
(all fields) 
Hand Searched 58/19 
' (("chronic obstructive pulmonary disease"[Text Word] OR "pulmonary disease, chronic 
obstructive"[MeSH Terms] OR copd[Text Word]) AND ("rehabilitation"[Subheading] OR 
"rehabilitation"[MeSH Terms] OR rehabilitation[Text Word]) AND (postrehabilitation [All 
Fields] OR long-term[ All Fields] OR ("quality oflife"[MeSH Terms] OR Quality OfLife[Text 
Word]) OR ("maintenance"[MeSH Terms] OR maintenance[Text Word])) AND English[Lang] 
AND "humans"[MeSH Terms]) 
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Upon retrieving and reviewing the 79 articles that remained, I again 
excluded articles that clearly did not focus on an exercise maintenance program 
following pulmonary, as well as excluding articles that lacked a 1 year follow-up 
post beginning the initial pulmonary rehabilitation program. Additionally, 
randomized controlled trials were preferred and studies without an adequate 
control group were excluded. Studies that did not use validated measures of 
outcomes were excluded as were studies that did not use an initial rehabilitation 
program of at least 6 weeks duration. Studies were also excluded if baseline 
patient characteristics were not reported or if the overall quality of the article was 
poor. (See Table 1 for search strategies and process). 
I kept aside articles of at least fair quality that followed up on patients at 
least one year after enrolment in an initial pulmonary rehabilitation program, 
articles that investigated the costs and benefits of pulmonary rehabilitation for at 
least one year after enrolment in an initial pulmonary rehabilitation program, and 
any study investigating maintenance therapy following a pulmonary rehabilitation 
program (See Figure 1 ). 
10 
FIGURE 1: Literature Review 
Citations identified by 
initial literature search: 
N=496 
Articles retrieved for in depth: 
review: N=79 
Articles not matching 
criteria: N=417 
Articles meeting 
criteria: N=3 
Articles retrieved 
1+------- for in depth -
reviewN=19 
Articles not 
meeting criteria--------
Articles of at least 
Abstracts 
reviewed that were 
identified by 
hand search N=58 
Articles 
excluded 
Articles of at least Articles of at least 
fair quality investigating 
maintenance therapy 
N=3 
fair quality investigating 
1 year follow up after 
initial enrohnent in 
puhnonary rehabilitation 
N=?•· o, 22. 34,36-38 
fair quality investigating 
costs and benefits of 
puhnonary rehabilitation 
N=6n, 2s-20 
Quality assessment 
I used a structured data abstraction to ensure consistency in appraisal of 
each article. I abstracted the following data from each article: characteristics and 
size of patient group; recruitment strategy; patient adherence and drop-outs; 
length of rehabilitation; length of follow-up, inclusion criteria, exclusion criteria, 
and outcomes measures. I assessed the external and internal validity of the studies 
and evaluated each article for overall quality. 
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Table 3: Evidence Table for Eligible Articles 
Study Quality Patient age Severity Groups (patients) 
Berry et. a!."" Fair Control mean age - Moderate to severe Control: 3 month exercise program- 70 began and 56 
66.9. completed. 
Treatment mean age = 
68.4 Treatment: 3 month exercise program followed by an 
additional IS month exercise program= 70 began and 62 
completed treatment. 
Ries et. a!:" Good 67.1 ± 8.2 Moderate to severe Control: 8 weeks pulmonary rehabilitation and referral 
back to PCP = 73 of 81 received standard care 
Treatment: 8 weeks pulmonary rehabilitation followed 
by self directed, at-home EM with weekly telephone calls 
and monthly supervised reinforcement sessions for 24 
months = 75 of 83 received intervention 
Weiner et. Fair Mean age of Control - Moderate to severe 3 month training with inspiratory muscle trainer = 
a1.47 64.9 all38 
Mean age of Treatment 
= 66.3 Control: additional12 months oflow-load training at 
home= 16 began and 9 finished. 
Treatment: additional 12 months training with inspiratory 
muscle trainer = 16 patients began, 12 finished. 
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Table 3: Evidence Table for Eligible Articles 
-Study Recruitment and Enrolment Adherence and Withdrawal 
Berry et. Before randomization, participants must Of the 70 control participants, 56 completed the trial. Of the 70 
al.46 have completed 3 screening visits (207 of treatment participants, 62 completed the trail. 
775) and completed at least 60% of the 
exercise sessions of a 3 month exercise Of all the measured outcomes in the treatment group, the 6 minute 
program (140 of775). walk test was the only outcome affected by compliance when broken 
down into tertiles (0-44%; 45-82%; 83-97%) 
Ries et. al.j 1 Patients must have graduated from After randomization, 6 patients (3 from each group) dropped out 
pulmonary rehabilitation to be eligible. For before starting treatment and 2 patients (1 from each group) withdrew 
the enrolment period of the study, 340 due to lung volume reduction surgery. An additional 1 patient from 
patients began the pulmonary rehabilitation the treatment group and 2 patients from the control group withdrew 
program and 190 completed the pulmonary before the 6 month assessment. The remaining group was assessed for 
rehabilitation program. 172 patients were outcomes. Ofthe remaining 82 patients in the treatment group, 7 
considered eligible, and all eligible patients patients died in first year, 10 died in the second year, and 0 patients 
were randomized. dropped out. Of the remaining 81 patients in the control group, 6 
patients died in first year, I 0 died in the second year, and 0 patients 
dropped out. 
Weiner et. Consecutive enrollment of pts. meeting 4 week run-in period with pts.' regular treatment. Pts. with poor 
a1.47 eligibility requirements from chosen compliance were excluded. Randomization to control or experimental 
community (65% of those recruited were occurred after initial 3 month pulmonary rehabilitation program ( 6 
eligible). Eligibility requirements excluded patients dropped out). From the 32 patients randomized, 11 dropped 
patients with poor compliance (see out: ( 4 experimental and 7 control). 
inclusion/exclusion criteria). 
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Table 3: Evidence Table for Eligible Articles 
Study Inclusion Criteria! Exclusion Criteria Comments 
Berry et. a!. •o FEVI/FVC :::70%; reported difficulty in ADL secondary to No disease specific HRQL or ADL 
dyspnea; had not participated in a pulmonary rehabilitation measurement tool used. 
program in the last 6 months; FEV1>20% of predicted; no 
severe cardiovascular or peripheral vascular disease; not No follow-up for the treatment group after 
undergoing treatment for cancer; no uncontrolled diabetes or long-term pulmonary rehabilitation ended. 
HTN; no plans to move away from the area within 15 months 
of beginning the study. Subgroup analysis of compliance by tertile 
indicates compliance was significantly 
associated with an improvement in 6-minute 
walk distance only. 
Ries et. aV' Clinical diagnosis ofCOPD confirmed by history, physical At one year post-maintenance, subjects in 
examination, pulmonary function tests, and chest both groups had returned to levels similar to 
roentgenograms; chronic symptoms and perceived disability baseline. There was no difference is 
from disease; stable on an acceptable medical regimen under survival over two years of follow-up 
the care of a primary care physician; no other significant between the two groups. 
medical or psychiatric conditions that would interfere with full 
participation in the program; commitment to abstain from 
smoking. 
Weiner et. al.41 For recruitment: FEVl <50% predicted or FEVIIFVC :::70%; How the community was chosen and how 
and diagnosed with COPD according to ATS criteria; no patients were recruited is not published. 
cardiac disease, no history of poor compliance, not requiring The number of pts. recruited and pts. 
supplemental oxygen, no carbon dioxide retention. eligible is not published. All pts. new to 
pulmonary rehabilitation. 
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Table 4: Outcome Measures 
Study Outcome Measures 
Berry et. Self Reported Disability: Treatment group reported 12% less disability than the control group at 18 m 
al.46 
6MW: Treatment group walked 100 feet further at 18m P= 0.03 
Dyspnea: Not measured 
FEVl/FVC: No significant difference between groups at 18m. 
Rieset. HRQL: Significant decline (CRQ, Rand-36) at 14m in both groups; no significant change (QWB) at 14m in both 
al.3t 
groups; significantly better maintained (lOPHS) in the treatment group at 14m. 
6MW: Significantly better maintained in the treatment group at 14 m 
Dyspnea: Significant decline in PB at 14 m in both groups 
FEVl!FVC: Significant decline at 14m in both groups. 
Maximum Treadmill Exercise: Significantly better maintained in the treatment group at 14m. 
Health Care Usage: Overall reduction in hospital utilization in the treatment group at 26m. 
Weiner et. HRQL: Not measured 
al.47 
6MW: Training group gained small benefit through 15m; control group declined toward baseline from 3m to 15m. 
Dyspnea: Training group gained small benefit through 15m; control worsened toward baseline from 3m to 15m. 
FEVl/FVC: No significant change in either group 
Inspiratory muscle strength: Training group gained small benefit; control declined toward baseline from 3m to 15m. 
HRQL: Health Related Quality of Life; 6MW: 6 minute walk distance; CRQ: Chronic Respiratory Questionnaire; Rand-36: Rand 36-Item Health Survey; QWB: 
Quality of Well-Being Scale; lOPHS: 10-point overall health scale; PB: Perceived Breathlessness; PI: maximum mouth inspiratory pressure. All time measures 
are measured from the beginning of the initial pulmonary therapy. 
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Table 5: Notable articles of interest that were excluded: Articles of at least fair quality investigating maintenance therapy following an 
initial pulmonary rehabilitation program and articles of interest comparing length of pulmonary rehabilitation programs. 
Study Main reason for Additional weakness Result 
exclusion 
Brooks>o Maintenance program Retention rates were poor in both Clear deterioration of functional exercise 
not an exercise program. groups: of the 109 eligibles, 24 capacity and HRQL in all groups without major 
No suitable control- dropped out after initial evaluation, differences between groups 
compared two post- and 44 dropped out over the course of 
rehabilitation programs the study (38% of eligibles remained 
at the end of the study). 
Elliott", No suitable control- Retention rates were poor: 3 7% of all Long-term outcomes could not be measured and 
compared hospital to participants in all groups remained at the effect of maintenance could not be 
home to community 1 year. calculated due to significant drop-out. 
based programs 
Foglio, 1·"" Investigated a repeat Recruitment and enrolment was Participants who repeated a pulmonary 
pulmonary rehabilitation limited to the compliant participants rehabilitation program at 1 year after 
program rather than of an earlier pulmonary rehabilitation completion on an initial pulmonary 
maintenance. program. Drop-out rate was rehabilitation program achieved immediate 
significant improvements in HRQL and decreased 
hospitalizations. These benefits diminish in the 
long-term with the exception that yearly 
exacerbations were reduced in the long-term. 
Articles were considered notable iftbey were often cited by guidelines, position statements, and the current literature concerning COPD rehabilitation. 
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Table 5: Notable articles of interest that were excluded: Articles of at least fair quality investigating maintenance therapy following an 
initial pulmonary rehabilitation program and articles of interest comparing length of pulmonary rehabilitation programs. 
Grosbois4 " Non-randomized No reporting of drop-outs during EM is associated with less diminishment of 
initial pulmonary rehabilitation improvement following pulmonary 
program. Patients self selected their rehabilitation over 18 months. 
maintenance program: EM twice 
weekly, EM once weekly, EM at 
home, no EM. 
Green°" Compared 4 weeks of a Differences existed between groups 7 weeks was superior to 4 weeks in terms of 
pulmonary rehabilitation in baseline shuttle walk test and immediate benefit 
program to 7 weeks of HRQL. 
pulmonary rehabilitation; 
insufficient follow-up 
Rossi" Observational prospective All patients enrolled in a 20 session Compared to measurements taken after 10 
trail comparing 10 sessions pulmonary rehabilitation program. sessions, the measurements taken after 20 
of a pulmonary Measurements taken after 10 sessions showed a statistically greater increase 
rehabilitation program to 20 sessions and compared to in 6 minute walk distance and HRQL from 
sessions of pulmonary measurements at 20 weeks. It is baseline. 
rehabilitation; insufficient unclear if the outcomes were due to 
follow-up. the additional sessions of pulmonary 
rehabilitation or were latent effects 
from the first 10 sessions. 
Articles were considered notable if they were often cited by guidelines, position statements, and the current literature concerning COPD rehabilitation. 
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Results: 
The 3 studies of good to fair quality all investigate patients with moderate 
to severe diseases.31• 46•47 The mean age of patients for all three studies range 
from 66.347 to 68.446• The patients in all three studies first must have completed 
an initial rehabilitation program to be included in the final analysis. Initial 
rehabilitation programs ranged from 8 weeks31 to 3 months.46• 47 The treatment 
groups in all three studies consisted of patients who enrolled in a year long 
exercise maintenance program following initial rehabilitation. 
All three studies report significant attrition of patients before 
randomization, either in selection or during the initial pulmonary rehabilitation 
program. Berry et. a!. report, of the 775 patients beginning the initial pulmonary 
rehabilitation program, 207 patients completed the program (73% attrition rate). 
Ries et. al. report, of the 340 patients beginning the initial pulmonary 
rehabilitation program, 190 patients completed the program ( 44% attrition rate). 
Weiner et. a!. report, of all the patients recruited, only 64% were eligible, and of 
the 38 patients eligible who began the initial pulmonary rehabilitation program, 
32 patients completed the program (84% attrition rate). 
A significant number of patients in all three studies dropped-out or died 
during the year of maintenance therapy. Berry et. a!. report, of the 140 patients 
randomized to maintenance therapy or conventional care, 118 patients completed 
the program (84% retention rate). Ries et. a!. report, of the 164 patients 
randomized to maintenance therapy or conventional care, 131 patients completed 
the program (78% retention rate). Weiner et. a!. report, of the 32 patients 
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randomized to maintenance therapy or low-load home-based training, 21 patients 
completed the program ( 65% retention rate). 
The three studies share two common outcome measures: 6 minute walk 
distance (6MW) as a measure of exercise tolerance and FEVl/FVC as a 
measurement oflung function. Weiner et. al do not evaluate health quality oflife 
(HRQL), quality oflife (QOL), or activities of daily living. Berry et. al. evaluate 
self reported physical disability as measured by the activities of daily living as 
captured by the Fitness Arthritis and Seniors Trial functional performance 
inventory. Ries et. al. measure HRQL through different instruments: Chronic 
Respiratory Questionnaire (CRQ), Rand 36-Item Health Survey (Rand-36), 
Quality of Well-Being Scale (QWB), and 10-point overall health scale (lOPHS). 
Of the tools used, the CRQ is the only disease specific tool, and the lOPHS is the 
only tool not independently validated. Berry et.al. do not measure dyspnea; Reis 
et. al. measure dyspnea using the UCSD Shortness of Breath Questionnaire and 
Weiner et. al. used the Borg scale. Reis also measure health care usage and 
maximal treadmill workload as estimated in terms of metabolic equivalents 
(METS) based on speed and grade. Weiner et. al. also measure maximum mouth 
inspiratory pressure. These tools and measures have been independently 
validated. 
Exercise capacity, as measured by the 6MW and the maximum treadmill 
exercise, was consistently higher in the treatment groups at the end of 
maintenance when compared to the control groups. Weiner et. al. and Berry et. 
al. demonstrate a continued improvement in the treatment group as compared to a 
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steady decline in the control group. Ries et. al. report declines in both the 
treatment and the control groups; however, the treatment maintained the benefits 
from initial pulmonary rehabilitation significantly better. 
HRQL, activities of daily living, and dyspnea differed by study as well as 
measurement tool. Using the Fitness Arthritis and Seniors Trial functional 
performance inventory, Berry et. al. demonstrate maintenance therapy was 
associated with 12% less disability. Using the Borg Dyspnea scale, Weiner et. al. 
demonstrate that from 3 months to 15 months after initiation of an initial 
pulmonary rehabilitation program, the training group continued to see small 
improvements (decrease in their Borg score) while the control group began and 
continued to worsen toward baseline. This difference became statistically 
significant from 9 months through 15 months. Reis et. al. use three different tools 
to measure HRQL and only the 1 OPHS illustrated an association of improvement 
with maintenance therapy at 12 months following the completion of an initial 
pulmonary rehabilitation program. It is important to note that the 1 OPHS has not 
been independently validated. All patients significantly declined in their CRQ 
and Rand-36 scores with no difference between groups. There was no significant 
change or difference in QWB in either group. 
No study was able to illustrate a difference between groups by comparing 
the FEVl/FVC. Ries et. al. demonstrate an overall reduction in healthcare 
utilization associated with treatment. This reduction was evident over the 1 year 
oftherapy and continued to be significant at 2 years. 
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Discussion 
The largest barrier to a sound recommendation is the lack of evidence is 
both quality and quantity. Exercise capacity, as measured by the 6MW and the 
maximum treadmill exercise, was consistently higher in the treatment groups at 
the end of maintenance when compared to the control groups, but this agreement 
is only within three studies of good to fair quality. HRQL, activities of daily 
living, and dyspnea differed by study as well as measurement tool. The two tools 
illustrating the greatest benefits are the Fitness Arthritis and Seniors Trial 
functional performance inventory 46 and the 1 OPHS31 • Neither tool is disease 
specific and the former is not a standard measurement tool while the latter has not 
been validated externally. Only one study used disease specific HRQL tools and 
Reis et. a!. could not demonstrate a difference using this tool. As is the case with 
previous rehabilitation studies, no study on maintenance programs were able to 
illustrate a difference between groups by comparing the FEVl/FVC 
The notable studies that did not meet the eligibility requirements (see 
Table 5) lack the rigor to be conclusive, but the trend of these studies is consistent 
with the fmdings of the three articles meeting criteria. Retention rates, 
recruitment, and enrollment are all problematic. Outcomes are varied from no 
effect to a modest benefit associated with maintenance. In the following 
discussion, HRQL as an outcome measure and the tools used to measure HRQL; 
the costs and benefits associated with pulmonary rehabilitation; and patient 
enrolment, recruitment, and compliance. 
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HRQL and Pulmonary Rehabilitation 
Recently, HRQL has been used to demonstrate the effectiveness of 
pulmonary rehabilitation to improve the outcomes of patients living with COPD. 
In theory, measuring changes in a patient's HRQL aids in understanding the 
intervention's effect on the patient's health; however, demonstrating a clear 
causal relationship is often difficult in practice. Pulmonary rehabilitation is 
associated with improved responses to HRQL questionnaires, yet a direct causal 
relationship between the pulmonary rehabilitation and improved health remains 
complicated with additional and unintended inputs that pulmonary rehabilitation 
may provide to patients: psychological benefits of the social aspects of pulmonary 
rehabilitation, more realistic expectations of the limitations secondary to the 
disease, coping skills. Secondly, the individual tools used to measure HRQL and 
how the investigators used these tools affect the validity of the measurement 
obtained. Lastly, an improvement in HRQL is often used as an outcome measure 
following pulmonary rehabilitation, yet as an outcome measure, HRQL lacks the 
strength it would have if a direct causal relationship could be proven between the 
therapy and the outcome. 
HRQL as an Outcome Measure for Pulmonary Rehabilitation. 
"Health" represents multiple variables: symptoms, the degree of disability 
or of ability to function, the degree of disease or to which one is free of disease. 
Each variable carries with it multiple connotations and "because of this 
multidimensionality, there is an almost infinite number of health states, all with 
differing qualities, and all quite independent oflongevity."52 We begin to tease 
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out the effect of an intervention on a person's health by combining the 
measurement a person's QOL and HRQL as it changes over the course of an ~ --
intervention with more traditional outcomes such as the rate of the progress of 
disease, mortality, change in functional status as measured by a six minute walk 
test or FEVl/FVC. This approach is different from limiting our observations only 
to how that intervention affects lifespan or other biological/physiological markers. 
Attempting to measure health involves moving away from provider-specific 
outcomes to outcome measures that are patient-specific. Provider-specific, 
physiologic outcomes do not reflect patient-specific outcomes. Physiologic 
measures such as FEVl/FVC do not correlate with the perceptions of patients 
living with COPD. Physiologic measures also may fail to detect important 
changes in health status. 53 
Current research increasingly uses HRQL as an outcome to evaluate 
pulmonary rehabilitation. pulmonary rehabilitation does not change affect 
mortality; however, pulmonary rehabilitation is effective in improving exercise 
capacity and HRQL in COPD patients.45 The strength ofHRQL assessment is 
that it is patient-centered and echoes the direction that health care has been 
moving- from a disease-oriented approach to a patient-oriented approach. 54 
Testa and Simonson state that while "the objective dimension is important in 
defining a patient's degree of health, the patient's subjective perceptions and 
expectations translate that objective assessment into the actual quality oflife 
experienced."54 
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However, this strength ofHRQL as an outcome measure is also a 
weakness ofthe tool. Testa and Simonson admit the difficulty in measuring 
health strictly from a QOL standpoint "Since expectations regarding health and 
the ability to cope with limitations and disability can greatly affect a person's 
perception of health and satisfaction with life, two people with the same health 
status may have very different qualities of life. "52 We should not conflate health 
and HRQL as the two clearly represent different aspects of a patient's existence; 
however, a patient's perception does not always discriminate such subtleties. 
Both the intervention of pulmonary rehabilitation and the measurement of 
HRQL are complex in their own right, and using the latter as an outcome measure 
of the former proves difficult. Even so, the complexity of the measure may be 
perfected suited for PR if the measure is obtained reliably. "Successful 
pulmonary rehabilitation requires patients to incorporate a complex array of 
changes in behavior (e.g., exercise, compliance with medications/oxygen, 
breathing retraining methods, lifestyle changes)."31 Additionally, the HRQL 
reflects "a person's own satisfaction or happiness with the life in the domains he 
or she considers important."54 In these complexities lies interconnectedness. 
HRQL may be more sensitive to detect the effects of pulmonary rehabilitation that 
teaches and trains patients to be successful in many areas in which the HRQL 
measurement tool is sensitive such as coping mechanisms and improved 
functioning. 
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Disease Specific HRQL Tools to Increase Specificity 
Wilson and Cleary state the "the concept of quality of life is distinct from 
health, though related to it,"55 and by measuring HRQL rather than general QOL, 
we can observe a more accurate relationship. HRQL allows a clearer 
investigation of the aspects oflife most affected by health: "dimensions of 
physical functioning, social functioning, role functioning, metal health, and 
general health perceptions. "55 
Additionally, COPD patients are a disease-specific population and the PR 
offered to these patients is fairly specific for those living with COPD. Such 
homogeneity, from a disease standpoint, allows the use of a disease-specific 
HRQL instrument. Given this population, one sacrifices very little with respect to 
generalizability to a population other than COPD patients because such 
generalizability is not a primary goal. Thus, a disease specific tool allows for a 
higher content validity. 
The studies of pulmonary rehabilitation using disease specific HRQL tools 
are relative since they are not generalizable to other conditions. The data 
collected using COPD-specific HRQL cannot be compared to patients with 
another disease. This lack of standard application limits the use of the research 
when the investigators only use a disease-specific HRQL tool. 56 For example, 
studies that employ only the CRQ or the St. George's Respiratory Questionnaire 
(SGRQ) to assess HRQL as an outcome measure of pulmonary rehabilitation 
could not be used to compare puhnonary rehab to cardiac rehab. Even with this 
limitation, using only a disease specific tool has benefits. Fewer questions spare 
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the patients the burden of filling out multiple disease-specific batteries or a 
combination of general and disease-specific assessments. Such a reduction in 
burden may increase the precision and accuracy of the single instrument. 54 With 
COPD and pulmonary rehabilitation, obtaining inunediate results favor a single, 
disease-specific tool; however, for future research and secondary analysis, 
collecting data with a general assessment may prove useful. 
Measurement ofHRQL as Reported in the Literature 
In a systematic review of the literature on pulmonary rehabilitation, Sin et. 
al.2 and Lacasse et. al. 18 illustrate that pulmonary rehabilitation improves HRQL. 
Both studies use many of the same articles and all 19 studies Sin et. al. selected 
for the systematic review used at least either the CRQ and/or the SGRQ to assess 
HRQL. The SGRQ (zero indicating no health impairment and 100 representing 
maximum impairment) consists of 50 items with 76 weighted responses and three 
component scores: symptoms, activities and impacts (psychosocial dysfunction). 
It is sensitive to changes in health status with treatment for COPD, and it is a 
valid and reliable measure of health status in patients with COPD.23 The CRQ 
includes 20 items in four domains: dyspnea (five items), fatigue (four items), 
emotional function (seven items), and mastery (four items), each item being 
graded on a seven-point scale.45 Some studies also collected data using additional 
generalizalble HRQL questionnaires as well as depression assessment: QWB, 
EADL, HAD. All assessment tools selected for comparision between the 19 
studies have been previously validated. 54 
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All 19 studies seem to use the tools within the populations for which they 
were intended as the clinical trials were investigating patients with chronic, fixed 
airway obstruction. The CRQ and SGRQ are both designed for such a population. 
However, Mishoe and Maclean propose that intended use goes beyond the 
specific population and even intended use is not sufficient by itself. In a disease 
specific questionnaire, "validity is relative; therefore, clinical trial protocols 
should incorporate the rationale and instructions for HRQL assessment to assure 
validity within the research study."54 Mishoe and Maclean go on to suggest that 
"clinical protocols should explain why, how, and when the HRQL assessments 
will be completed, provide justification for instruments selected for use and 
descried how these data will be analyzed," as well as the burden placed on 
patients in terms of time spent waiting to answer and answering the 
questionnaire. 54 
While most of the 19 studies state their rationale and a brief explanation of 
how the assessment was conducted, the variation in details are great. Some 
studies provide no details of the manner in which the questionnaires were 
administered, and other studies lacked information regarding the language and 
contained no rationale. Some studies made an attempt to discuss the timing of 
assessment, but, qnite often, these data were quite limited. For example Ries et. 
a!. provide information on the rational and the fact that the questionnaire was 
given at different times, yet the timing was not discussed. "TheCRQ was 
administered by an interviewer. This disease-specific quality oflife instrument 
evaluates four domains: dyspnea, fatigue, emotional function, and mastery. 
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Patients were asked to rate overall health status on a 10-point scale ranging from 0 
(dead) to I 0 (excellent). In addition, this was obtained routinely by rehabilitation 
staff at the first contact (to assess the effect of screening).'.31 
While data on how the researchers conducted the questionnaire were 
available in some studies, this information was often at the expense of the 
rationale. "Patients were assessed using a standard 6-min walk, and completed 
the SGRQ; both tests were supervised by a blinded observer who subsequently 
repeated these assessments at 12 weeks and 24 weeks. Patients were then 
randomized to either the rehabilitation program or to routine outpatient attendance 
at 3-month intervals. Randomization was in blocks of 10, using random 
numbers."24 A small minority of the studies explained their methods in using a 
questionnaire?3• 57' 58 
Larson et. a!. explain, "The Chronic Respiratory Questionnaire (CRQ) was 
used to measure the intensity of dyspnea and fatigue experienced by patients on a 
daily basis. Guyatt and colleagues recommended that subjects be informed of 
their most recent answer on each item before giving their current answer. For the 
purposes of this study we blinded patients to their responses on previous visits. 
This was done to minimize the bias to report improvement, because most patients 
anticipate benefits from exercise training. The reliability of this modified 
technique was supported by acceptable test-retest reliability when the instrument 
was administered twice to patients with COPD, with a 1-wk interval between 
administrations. The test-retest reliability coefficients were as follows: CRQ 
Dyspnea, r 5 0.73, df5 48; CRQ Fatigue, r 5 0.69, df5 68 (our unpublished data, 
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1998). The CRQ has been widely used in surveys of patients with COPD and its 
validity has been established."57 
Larson et. al.57 and Stnlbarg et. al.58 discuss many of Mishoe and 
Maclean's suggestions as well as the use of blinding patients' previous responses 
versus supplying the patients with their previous responses. Such blinding may 
reduce recall bias in that patients may want to be better after a rehab program, yet 
some studies suggest that by supplying patients with their previous responses, the 
responsiveness of the assessment is improved. Interestingly, all these studies had 
similar results. None of the studies included information that would be useful in 
determining the burden placed on patients. 
Assessing the Relationship between Pulmonary Rehabilitation, 
Exercise Maintenance and HRQL 
The studies reviewed show the same directional relationship in the 
improvement ofHRQL associated with both pulmonary rehabilitation and 
exercise maintenance. This fmding is consistent with the body ofliterature 
available concerning pulmonary rehabilitation and COPD. Although it may be 
tempting to articulate a causal relationship, data are insufficient to claim that 
pulmonary rehabilitation caused the improvement. First, the strength of the 
relationship is weakened by the fact that only 2 of the 19 studies investigated by 
Sin et. al. illustrate rigor in their attention to the delivery of the HRQL 
t 57 58 H thi fd 1' . . . b assessmen s. · owever, s aspect o e 1very 1s a mmor pomt, not ecause 
of the overall quality of the studies, but because more important factors challenge 
causal relationships derived by HRQL assessment. 
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As Wilson and Cleary demonstrate that there is an association between the 
HRQL measured and the clinical measures of disease. The association between 
HRQL and general perceptions of health is important because general perceptions 
of health are strong predictors of mortality. 55• 59 However an association is not 
sufficient to prove casualty; additionally, predictions can be made using 
associations but, likewise, prediction is not sufficient to prove causality. Further, 
all studies failed to show a change in mortality, which raises the suspicion that 
rather than an organic change of true functioning, patients may be changing "their 
expectations and aspirations as circumstances change. "55 
Adding to the skepticism, some studies "suggest that assessment ofHRQL 
can lead to improvements in HRQL."55 The change in expectation and the 
psychological component that a patient in PR receives from receiving treatment 
leads to the introduction of a significant source of bias. It is extremely difficult to 
devise a plan where patients would engage in placebo pulmonary rehabilitation 
and be blinded. Additionally, the role of interacting with others and engaging in 
introspection about their disease is unknown. Some ofthis bias is controlled by 
offering the control patients education and the fact that all participants answer the 
questionnaire, but the effect of the rehab itself is difficult to isolate. 
We have yet to resolve the consequence of the introduction of bias and 
confounding. "There has been relatively little research to date that either 
explicitly conceptualizes the relationships of clinical variables to measures of 
HRQL or attempts to determine the intervening variables that mediate these 
effects."55 HRQL as an outcome measure is not unlike many measures in that the 
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effectiveness remains difficult to measure and one must remember that HRQL is 
not a sole measure. Taken with other measures, HRQL remains a useful tool is 
assessing patient-related outcomes in the face of provider-specific physiological 
measures. Finally associations are not useless; some studies demonstrate 
"measures ofHRQL can be as sensitive to clinically important changes as 
traditional clinical variables and can detect important differences not assessed by 
such endpoints."55 Even ifHRQL is a surrogate for other unmeasured variables, 
HRQL challenges us to seek those variables in evaluating patent care form both 
the providers' and the patients' perspective while being a valuable predictor of 
other hard outcomes. 
Cost-Effectiveness of PR 
In addition to determining the HRQL, as complete of a picture of the 
benefits derived from pulmonary rehabilitation is needed to determine the true 
benefit of rehabilitation. This benefit can then be compared with the cost of 
therapy. While the results of cost-benefit analyses and studies of hospital 
utilization show promising results for pulmonary rehabilitation as a life enhancing 
and cost reducing (or at least a cost effective) treatment, the long term effects 
must be studied further. More studies with greater numbers of participants over 
longer periods of time are needed to better evaluate the cost-effectiveness of 
pulmonary rehab. Especially important is whether the cost savings or cost 
neutrality of pulmonary rehabilitation is sustainable or if the programs merely 
postponed the inevitable costs of the disease. If sustainable cost savings are not 
31 
possible, HRQL improvements must be weighed against the costs in order to 
create guidelines for the most efficient use of resources 
As stated in the introduction, COPD, while treatable, is not curable and 
ultimately life ending. Additionally, as discussed in the introduction, the 
literature agrees that pulmonary rehabilitation for COPD is efficacious in 
improving health related quality oflife for some period of time. Recent studies 
suggest that pulmonary rehabilitation may be a cost effective treatment for those 
who live with COPD. 17• 25.29 These studies investigate the costs and benefits of 
pulmonary rehabilitation as well as hospital utilization. While the results are 
favorable, the studies are not of the highest quality and the effects beyond one 
year must be studied further. 
Golmohammadi et. al. used a pre-post comparison to investigate the cost-
effectiveness of a community-based pulmonary rehabilitation program for COPD 
patients with mild, moderate, and severe disease.Z5 The investigators studied 210 
patients living with COPD one year before and after completion of rehabilitation 
and compared the direct costs (in Canadian dollars) and disease-specific quality of 
life to the data obtained on 592 COPD patients from the same region who did not 
participate in the rehabilitation program. The average reduction of total costs 
before and after the program was $34,367 per 100 person-years attributed to an 
associated decreased health service utilization, reduced direct costs and improved 
health status ofCOPD patients. 
Hui et. al. and California Pulmonary Rehabilitation Collaborative Group 
conducted a similar study. Hui et. al. preformed a similar pre-post comparison as 
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part of a prospective longitudinal study investigating the efficacy of a simple 
outpatient-based pulmonary rehabilitation program in improving health outcome 
and hospital utilization in patients with COPD. The investigators studied patients 
from the outpatient physiotherapy department at a district general hospital who 
completed of a simple pulmonary rehabilitation. Hui et. a!. found that in the 12 
months following completion of program, hospitalization and length of stay were 
reduced compared to prior to starting the program (preprogram, 7.4 days; 
postprogram, 3.3 days; p < 0.005).17 
The California Pulmonary Rehabilitation Collaborative Group preformed 
a similar pre-post comparison to evaluate pulmonary rehabilitation as practiced in 
the general California medical community.28 Dyspnea, HRQL, and reducing the 
use ofhealthcare resources were studied by investigating the common clinical 
health outcome data on consecutive patients at 10 established pulmonary 
rehabilitation programs over 2 years. Nine of the ten centers agreed to participate 
and of the 647 patients that met prespecified inclusion criteria, 521 completed the 
rehabilitation program and both the pre- and the postprogram assessment. After 
rehabilitation, there were significant reductions in all measures ofhealthcare 
utilization a well as improvement in HRQL over 18 months. The high completion 
rate (relative to other studies of pulmonary rehabilitation) highlights the 
recruitment and enrolment were based on patients who were referred to a 
rehabilitation program, chose to attend, and could afford to attend. This bias 
affects the generalizability of this study. 
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For these three studies, the absence of a control group, it is difficult to 
ascertain the effect of increased monitoring and access to care upon the outcomes. 
Additionally, the enrolment for both studies was done through referral rather than 
serial enrolment or active recruiting. The design of these studies is not as strong 
as a randomized controlled trial, and while the results suggest that pulmonary 
rehabilitation is cost-effective, one may reason that the health care expenses may 
be shifted to later years. However, since pulmonary rehabilitation is not 
associated with a change in survival, one may also reason that there is no shifting. 
Rather, patients may live in a more healthy state for the same number of years. 
Griffiths et. al. used an RCT to assess the effect of outpatient pulmonary 
rehabilitation on use of health care and patients' wellbeing over one year and 
report pulmonary rehabilitation appears to be an effective intervention in patients 
living with COPD.26 The investigators studied 200 patients who were randomly 
assigned a 6-week multidisciplinary rehabilitation program or standard medical 
management. Data was gathered on the use of health services and assess via an 
ITT analysis. The ITT analysis is a major strength of this study and is relatively 
unique in that the results are based on the patients that began rehabilitation rather 
than on those who completed the program. There was no difference found 
between the rehabilitation and control groups with regard to the number of 
patients admitted to the hospital. However, the average number of days these 
patients spent in hospital differed significantly: 10.4 days vs. 21.0 days, p=0.022). 
Rea et. al. 27 compare the effect of a multi-disciplinary disease 
management program with conventional care, on hospital admissions and quality 
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oflife. The investigators studied one hundred and thirty-five COPD patients that 
were recruited and emolled based on hospital admission data and general practice 
records. The randomization for this study was conducted by randomizing entire 
general practices to either conventional care or a disease management program. 
Admission data was then compared for 12 months prior to and during the trial. In 
the year following rehabilitation, the mean hospital bed days per patient per year 
were reduced from 2.8 to 1.1 in the rehabilitation group, and increased from 3.5 to 
4.0 in the conventional group. 
While this study uses a pre-post comparison, there is also a randomized 
arm to which the treated group can be compared. Another strength of this study 
was patient retention. Randomization occurred before eligibility was determined 
and of the 99 patients randomized and eligible for rehabilitation, 71 completed the 
12 month assessment (16 refused to participate at the onset). Such compliance in L 
studies on pulmonary rehabilitation is rare. This study is promising in that a 
chronic disease management program reduced admissions and hospital bed days; 
however, this program is much more elaborate than pulmonary rehabilitation 
alone. The program study contained elements of all the following: "a COPD 
management guideline, a patient-specific care plan and collaboration between 
patients, general practitioners, practice nurses, hospital physicians and nurse 
specialists with conventional care, on hospital admissions and quality of life. "27 
Goldstein et. a!. carried out a RCT of rehabilitation comparing 
conventional community care to 6 months of respiratory rehabilitation and 
investigated the incremental costs associated with improvements in HRQL.29 The 
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treatment group underwent 2 months of inpatient rehabilitation followed by 4 
months of outpatient supervision. Of the 89 subjects 78 remained at the end of the 
study (38/45 in the treatment group and 40/44 in the control group).Five subjects 
who were withdrawn for medical reasons and two for renewal of smoking. One 
subjects dropped out and was noncompliant with completing the outcome 
measures and three others dropped out due to issues relating to travel or anxiety. 
No explanation was given for the exceptional compliance rate. 
All costs (hospitalization, medical care, medications, home care, assistive 
devices, transportation) were included. In determining what defined cost, the 
viewpoint society was taken in that costs were included regardless of the payee: 
government, private insurers, or the patients. In determining the incremental cost, 
the investigators used improvements beyond the minimal clinically important 
difference. The incremental cost was $11,597 (Canada); 90% of the cost was 
associated with the initial phase of hospitalization. Goldstein et. a!. determined 
the cost-effectiveness ratio for dyspnea was $19,011 per unit difference and 
$35,142 per unit difference for fatigue. However, when looking atthe minimal 
clinical difference, the cost required for a single patient to achieve a benefit 
greater than the minimal clinical difference is $47,548 for dyspnea, and $51,027 
for fatigue. 
These studies highlight the power of disease specific self-management 
programs that include pulmonary rehabilitation and pulmonary rehabilitation 
alone in terms of decreasing hospital utilization. Additionally, data obtained 
through health related quality oflife (HRQL) measures demonstrate the 
36 
effectiveness ofPR to improve the lives of patients living with COPD. HRQL 
measures as well as decreased patient hospital usage elevate the value of 
pulmonary rehabilitation. However, the efficacy of rehab is limited in its effects 
on mortality. As discussed in the introduction, domiciliary oxygen therapy and 
smoking cessation are the only therapies that have been shown to prolong survival 
and slow the decline of lung functioning respectively.1• 2 The data are also limited 
in terms of the sustainability of the benefits after rehab due to the limited number 
of quality studies as discussed earlier in this paper .. 
Economic Burden of COPD and the Costs of Pulmonary 
Rehabilitation and the Benefits 
In addition to the costs mentioned in the introduction, COPD is similar to 
other chronic diseases in that I 0% of patients account for 73% of expenditures? 
Hospitalization is one of the costliest components of the health care of patients 
living with COPD. The National Medical Expenditure Survey estimated 
hospitalizations for patients with COPD were 2.7 times as costly, per capita, as 
those without. 3 
HRQL measures and patient hospital utilization allow the medical 
community to better evaluate the effect and the cost-effectiveness of pulmonary 
rehabilitation as a treatment for COPD. The data on cost-effectiveness is limited, 
and while the quality on most of the studies cited above are not of high quality, 
the data suggest pulmonary rehabilitation is cost-effective.25 Golmohammadi et. 
a! compared the direct costs and disease-specific quality oflife of patients living 
with COPD. The group measured cost in Canadian dollars and HRQL by the 
SGRQ which has been validated as detailed in the HRQL section of this 
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discussion. This was not a randomized controlled trial and the pre-post 
comparison is a weak study design, yet the results urge further investigation. 
When compared to the cohort who did not receive rehab, the average reduction of 
total costs attributed to rehab participation was $34,367 per 100 person-years or 
approximately $344 per person per year (p = 0.02). "Over one-year, pulmonary 
rehabilitation was associated with decreased health service utilization, reduced 
direct costs and improved health status of COPD patients. This suggests that 
pulmonary rehabilitation is cost-effective for "patients with relatively high 
utilization of emergency and hospital-based services."25 
The California Pulmonary Rehabilitation Collaborative Group posits many 
of the previous cost-effectiveness studies were "conducted in a different era of 
medical practice in the United States during which it was much more common to 
admit patients to hospitals for treatment of exacerbations and complications of 
chronic lung disease"28. Newer treatments and practices use inpatient facilities 
less frequently for the treatment of COPD exacerbations. While it is conceivable 
that this previous data may have overestimated the savings from reduced 
hospitalizations, the group found that such suspicions were unlikely. In the 
group's analysis, "there were significant and consistent reductions in important 
measures of resource utilization over 18 months of follow-up evaluation including 
hospital days, urgent care visits, physician office visits, and telephone calls to 
physicians."28 The most notable result of the study demonstrates an average of a 
6.6 day reduction in hospital stay per hospitalized patient in the year following 
pulmonary rehabilitation. As stated above, the design of the study makes these 
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results poorly generalizable. Additionally, the sustainability of this savings is 
questionable as to whether it is a true cost savings or cost-shifting to a later time. 
Taken apart, the quality of the studies make the results questionable and 
publication bias may affect the reporting of studies that show pulmonary 
rehabilitation is not cost-effective. However, the general trends of the studies are 
consistent with one another. Patients who completed pulmonary rehabilitation in 
one study spent an average of 10.6less days in the hospital than the control 
subjects;26 after PR, patient's episodes of hospital admissions per patient per year 
fell from 1.2 to 0.6, p=0.005 and mean length of stay fell from 7.4 days to 3.3 
days, p=0.01 in another study.17 Patients who participated in a disease 
management program including pulmonary rehabilitation were hospitalized nearly 
half as often and spent over one third less time hospitalized in the 12 months 
following rehab as in the 12 months prior to rehab.Z7 
There is a measurable monetary savings associated with this reduction in 
hospital usage. Golmohammadi et. a!. found an average reduction of total costs 
attributed to rehab participation of $344 (Canadian) per person per year.25 Such 
results suggest pulmonary rehabilitation has the potential to cut spending on 
hospitalizations and emergency department visits. Less decisively Griffiths et. a!. 
suggest a similar economic benefit. The costs and benefits resulting from a 6 
week outpatient rehabilitation program were studied using net cost in pounds and 
net utility in terms of quality adjusted life years (QAL Ys) gained by adding 
pulmonary rehabilitation to standard care. The investigators found that rehab had 
a 64% chance of being less expensive than providing standard care alone. While 
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not much better than a coin toss, by adding the QAL Y s gained to the analysis, 
Griffiths et. a!. illustrate a benefit. On a purely monetary level, the trend suggests 
a reduction in the yearly cost of rehab when compared to standard care, but the 
95% CI crosses the null: £-881 and £577. Cost reduction cannot be proven given 
the available data; however, Griffiths et. al. demonstrate that the upper end of a 
rehabilitation program is £577, with a 64% chance that rehabilitation will actually 
save money. In addition to the possibility of a negative cost, on average, patients 
undergoing rehab received 0.030 (95% CI 0.002 to 0.058) QAL Y s per patient.26 
Such data must be assessed for cost efficiency. 
Even if pulmonary rehabilitation cannot achieve a cost reduction or cost 
neutrality, pulmonary rehabilitation has the potential to improve the HRQL and 
exercise capacity of patients living with COPD. A strong recommendation would 
have to be given to a cost neutral program that improved HRQL and increased 
QAL Y s. A large study with sufficient power or several additional smaller studies 
may be able to decisively prove that a cost neutral program is possible and may 
even prove that rehab decreases costs. Even if a cost neutral program is not 
possible, a low cost program that improves HRQL deserves consideration. 
Problems with the Current Cost Measures 
The current studies have significant data that illustrate the reduction of 
hospital usage over one year following pulmonary rehabilitation and the 
improvement in HRQL for patients living with COPD during the year following 
pulmonary rehabilitation? While the data are convincing for the year following 
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pulmonary rehabilitation, few studies investigate hospital usage after 12 months 
and fewer studies investigate the cost-effectiveness of rehab. The Griffiths study 
provides a good example of the promise of and the problems with the existing 
cost-effective analyses. 
In the Griffiths study, the number of patients was sufficient to show that a 
low cost program was probable and that a cost neutral or money saving program 
was possible. Additionally the number of patients was sufficient to show an 
increase of QAL Y s. However, there were not enough participants to avoid using 
a modeling technique in order to obtain sufficient power. Additionally, the 
QAL Y s gained per patient may be artificially low due to the lower number of 
participants and the lack of a significant time of follow-up. However, the lack of 
significant follow-up time could give an artificially low cost for pulmonary 
rehabilitation by postponing inevitable sequelae by cost shifting these inevitable 
costs to a period of time beyond the study.26 
Lastly, cost neutrality is not the only consideration. The medical 
community has a duty to improve HRQL, however limited by resources and 
patient autonomy.60 Valuing a QAL Y or a point on a HRQL questionnaire in 
dollars is debatable, yet we must determine, either at the individual or societal 
level, the point at which the marginal benefit in terms ofHRQL equals the 
marginal cost of providing that service. Until better data are collected, health care 
providers will have to make these decisions on an individual level with imperfect 
data. 
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The Studied Population 
Even the most sophisticated cost analysis is limited by the population 
studied. Patient recruitment and compliance with treatment are key issues in 
investigating pulmonary rehabilitation programs and designing randomized 
controlled studies to study patient outcomes following a pulmonary rehabilitation 
program. Compliance is an essential part of pulmonary rehabilitation. Patients 
have many reasons for not finishing the program or for not following up with the 
research team after completing a therapy. ITT allows a more realistic measure of 
effectiveness and provides better generalizabilty. Another factor that is a 
potential for bias is the recruitment process. Depending on the recruitment 
process, the study population drawn from the potential participants may be very 
different from the target population. In evaluating the effectiveness of pulmonary 
rehabilitation, especially repeat a pulmonary rehabilitation program or long term 
pulmonary rehabilitation, the type of patients recruited may help shape a study 
population that responds. One of the major limitations of the current data is that 
the data are gathered from only those participants that attend the programs. Very 
little data has ever been gathered regarding the potential candidates who did not 
participate either due to exclusionary criteria or by their own declination to 
participate.13 
Recruitment, Enrollment, and ITT 
Recruitment information would enable providers to make better decisions 
for their patients living in the real world. 61 Patients at various levels of disability 
respond to pulmonary rehabilitation differently and the type of patient may 
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influence willingness to enroll in a study as well as attractiveness to the 
researches. For example, "patients with reduced exercise capacity who 
experience less ventilatory limitation to exercise and more reduced respiratory 
and peripheral muscle strength are more likely to improve with exercise 
training."8 Given this information, it is reasonable to question if those patients 
with the greatest chance of response would not be recruited due to their own lack 
of interest or the researchers' own bias directed against targeting a sicker patient 
in the recruitment process. Such preferences would introduce bias that would 
move results toward the null for two significant reasons. Healthier patients may 
have less of a response to treatment and will appear more similar to the controls. 
Additionally, healthier patients may, on their own volition, exercise or practice 
better habits; such behavior would make the control group look more similar to 
the experimental group. 
Dropouts, cross-overs, and patients lost to follow-up also play a large role 
in puhnonary rehabilitation program. A high dropout rate is evident in many 
studies ofPRP's. Elliot et. a!. report a dropout rate of73% at 12 months 
following an initia13-month program.43 and another high quality study by Brooks 
et. a!. reports 50% of the patients did not complete the follow-up period. 36 
Recruitment, enrohnent, and compliance play a major role in introducing bias to 
the results of studies evaluating the effects of pulmonary rehabilitation. In a 
simple, yet effective, descriptive study, Young et. a!. compiled data on eligible 
subjects who did not participate in a COPD rehabilitation program. These 
subjects were not more physiologically impaired, but "were more likely to be: 
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socially isolated, lack chronic obstructive pulmonary disease-related social 
support, still be smoking and be less compliant with other healthcare activities."62 
Foglio et. a!. represents a study that asks a good question and has a strong 
study design, but fails to obtain a reliable answer due to poor recruitment 
practices, poor enrohnent practices, and a lack of analysis on the drop-outs. 37• 48 
The study enrolled sixty-one consecutive patients with stable chronic airway 
obstruction (CAO). These patients were recruited from an earlier study 
investigating an initial 8-week puhnonary rehabilitation program (PRP 1 ). The 
recruitment and enrolhnent in the initial study was based upon seventy-one 
consecutive CAO patients in a stable condition. In the original study, complete 
data sets were obtained from sixty-one out of the seventy-one patients. "Six 
patients were lost at follow-up and four patients were excluded from the study 
owing to intervening physiological (one asthmatic patient became pregnant) or 
pathological conditions (one renal cancer, one stroke, one orthopaedic l problem)."37 Neither the original study paper nor the final paper discussed the 
recruitment any further than to state that the patients were consecutively enrolled 
before randomization. All the participants were ex-smokers, in stable condition, 
and free from exacerbations. The authors did not state whether these 
characteristics were intentionally recruited, part of an exclusionary or inclusionary 
requirement, or by chance in the fmal paper; however, the original paper stated l 
that being a current non-smoker was a requirement. The authors did state they 
excluded patients with other organ failure or cancer, or who "were unable to 
cooperate."37• 48 
44 
Response to treatment and the reasons for dropout may be affected by 
recruitment as could how the discharge instructions may be followed by different 
types of patients. After discharge from each pulmonary rehabilitation program, 
the patients were encouraged to perform daily life activities, but no structured 
exercise programs were prescribed and "after completing PRPI, patients were 
asked "to keep a record of hospital admissions and exacerbations for the 
following 2 years."48 It is reasonable to question if a more motivated patient 
would follow discharge instructions differently and be more prone to stay emolled 
in the study. Such motivation would move the result toward to null and 
recruitment may have affected the motivation of the participants. 
Foglio et. a!. state they evaluated sixty-one CAO patients I year after the 
patients completed PRPI; however, how the investigators choose these sixty-one 
patients is unknown and unstated. Additionally, the original pool of seventy-one 
patients who were recruited for PRPI and the group who completed PRPI were 
not discussed and their numbers were never stated in the fmal paper. The original 
paper must be accessed to gain this information. Regardless, the sixty-one 
patients were randomly assigned either a second pulmonary rehabilitation 
program (PRP2) or normal care and 36 were still emolled at the end of the study 
as the published flow chart illustrates (Figure 2). 
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Figure 2: The timeline used by Foglio et. a!. 48 
The investigators only reported dropouts after Tl. They give no 
explanation as to why, what type of, or how many dropped out of the study from 
TO through PRP 1 and up until Tl. While no patient died during the study and all 
thirty patients who began PRP2 finished the program, there were significant drop 
outs after PRP2. "Eleven patients in group 1 and 10 patients in group 2 did not 
perform evaluations at T4 due to personal, transport, or familial problems. Four 
more patients (two patients in each group) were excluded from the study due to 
intervening pathologic conditions (one bladder cancer, two limb traumas, one 
sudden onset of ischemic heart disease)". The investigators did not do an ITT 
analysis; instead, "complete data sets were obtained from 17 patients in group 1 
and 19 patients in group 2."48 
One must assume that the investigators felt reassured that the "dropouts 
did not differ from patients evaluated in any anthropometric, clinical, or 
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functional characteristics recorded at TO, T2 (Figure 2), or, in the case of group 1, 
at T3" and that since "neither hospitalizations nor exacerbations in the 2 years 
preceding PRPl were different between the two groups. The dropouts from the 
two groups were generally similar.'48 Regardless, by choosing to only analyze 
the data from those who maintained follow up selects a specific type of patient. 
External validity is negatively affected as is internal validity. External validity is 
threatened in that the patients remaining in the study likely are not similar to the 
target population. 
The several stages of eligibility and poor reporting make determining the 
eligibility fraction impossible. Even ifthe authors did include the number of 
potential participants, these participants came from a pool of previous participants 
with their own eligibility, enrollment, and recruitment fractions. This selection 
creates participants who may not represent the target population. Such selection 
conjures the image of salmon swimming upstream and surely, those thirty-six 
participants who are included in the complete data sets are quite different than the 
average patient contemplating repeating a pulmonary rehabilitation program. 
In a second study, Ries et.al. are clearer in their criteria and from what 
target population participants were recruited, yet they fail to explain how the 
target population was approached. The investigators report "patients with chronic 
lung disease were recruited from University of California, San Diego (UCSD) 
Pulmonary Rehabilitation Program graduates."31 The selection criteria are stated, 
but there is no information as to the methods of recruitment and how these 
methods may have influenced the eligibility fraction. 
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Over a 4-year period, 340 patients enrolled in the pulmonary rehabilitation 
program, 190 patients completed the pulmonary rehabilitation program and were 
eligible for the study, 172 of these patients agreed to participate and were 
randomized to either the experimental maintenance program or standard care 
control for 1 year. Six patients were withdrawn due to a failure to complete 
required post-rehabilitation assessments before the experimental intervention and 
two patients had lung volume reduction surgery within 6 months. 13 patients 
did d3 f t 'thdr e an 'ua tens WI ew. p· umre 3 ·n str t th 1 u a es ese dta a 
Figure 3: Patient Enrollment and Assessment in Ries et.al. 31 
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The differences between control and treatment groups may be exaggerated 
when one looks at who continues the rehab program after completing the 
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maximum number of sessions that insurance will cover. To look at patients who 
are already in rehab introduces a group that would be dramatically different than a 
control group of COPD patients not in rehab: access, means, compliance to 
medication regimens, quality of care, home environment, family/community 
support, education level, smoking status, fitness level and prior fitness level, and 
motivation. These many differences introduce bias affecting both internal and 
external validity. The cases become very different from both the general 
population and the controls. Due to problems with recruitment, from any control 
group may also become different than the general population. 
Conclusions 
Current research is limited by quality and quantity; however, continued 
exercise maintenance therapy appears associated with modest improvements in 
exercise capacity, but not with any difference in lung function. Results were not 
conclusive of a benefit in HRQL or dyspnea. Further research is needed to 
confirm the associations and further investigate the affects ofHRQL and dyspnea. 
The problems with patient enrolment, recruitment, compliance, and 
retention rates are central in the generalizability of studies investigating 
pulmonary rehabilitation. Currently, the data discussed in this paper can only be 
generalized to patients who are willing, able, and motivated to complete 
rehabilitation. Further, these more motivated patients with means remain the only 
available subjects for rehabilitation study as those lacking the motivation or the 
means to attend rehabilitation will continue to dropout of or fail to participate in 
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physical rehabilitation. Current research is already being conducted to investigate 
how various modalities of rehabilitation affect motivation; however, the time and 
opportunity cost to the patient of rehabilitation must also be considered. 
Lastly, while data suggests that pulmonary rehabilitation is cost effective, 
more research is needed to make this case more clearly. Further research is also 
needed to make a case for the cost effectiveness of exercise maintenance therapy. 
At present, the research does not provides enough data to make any informed 
statement as to the cost incurred or cost saved by a program of exercise 
maintenance therapy following initial rehabilitation. The findings ofRies et. al. 
suggest that maintenance therapy must be continued in order for benefits to be 
sustained. This fmding will make the task of cost analysis more complicated. 
In conclusion, the data suggests that continued exercise maintenance 
therapy is associated with modest improvements in exercise capacity; however, 
the cause of this improvement remains unclear. Lung function remains 
unchanged by continued exercise maintenance therapy. Furthermore, the results 
were not conclusive as to a benefit in HRQL or dyspnea. The selection and 
recruitment bias that exists within the studies regarding pulmonary rehabilitation 
weakens the generalizability of the data reported. Further research is needed to 
confirm the associations and further investigate the affects ofHRQL and dyspnea 
following pulmonary rehabilitation and maintenance therapy. 
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